Robot model
Butterfly AI Ultrasound
Butterfly Network develops AI-powered handheld ultrasound technology, including the Butterfly iQ+ and Butterfly iQ3 probes that enable whole-body imaging from…
- Manufacturer
- Butterfly Network
- Form factor
- biometric
- Maturity
- commercial
- Lifecycle
- active
- Deployments
- 1
The verified answer
As of Aug 2026, DEPLOY verifies Butterfly AI Ultrasound, a biometric by Butterfly Network (commercial): 1 verified deployment on record. 1 source back the record.
Overview
Butterfly Network develops AI-powered handheld ultrasound technology, including the Butterfly iQ+ and Butterfly iQ3 probes that enable whole-body imaging from a single semiconductor-based device. Founded in 2011 by Dr. Jonathan Rothberg, the company went public via a $1.5B SPAC merger with Longview Acquisition Corp. in February 2021 and trades on NYSE under BFLY. The company has received multiple FDA clearances for AI-powered ultrasound tools and deploys across health systems including Atrium Health and Hennepin EMS.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Sources on file
- View all sources →
Key facts
Type
Data & sources
News coverage
1
1 source backing this record.View all →
Pricing
No verified price is on record for Butterfly AI Ultrasound. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Deployments (1)
Atrium Health deployed a large fleet of Butterfly iQ devices used to perform thousands of scans during the COVID-19 pandemic.
Butterfly AI Ultrasound on the deployment map
View the global mapWhere Butterfly AI Ultrasound is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 3, 2026
Added to the verified registry
- Deployment verifiedVerifiedApr 1, 2020
at Charlotte, North Carolina, USA
- Incident recordedFeb 24, 2020
FDA Class 2 recall of Butterfly iQ Auto Bladder Volume Tool for lacking 510(k) clearance
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Incidents affecting Butterfly AI Ultrasound (1)
Includes incidents linked directly to this model or to deployments of it. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Sources (1)
Common questions
What is Butterfly AI Ultrasound?
How much does Butterfly AI Ultrasound cost?
Is Butterfly AI Ultrasound actually deployed in the real world?
Who makes Butterfly AI Ultrasound?
Where is Butterfly AI Ultrasound deployed?
Can you buy Butterfly AI Ultrasound?
What are alternatives to Butterfly AI Ultrasound?
How does Butterfly AI Ultrasound compare to Blackrock Neuroport Array?
Is Butterfly AI Ultrasound a top biometric?
What is Butterfly AI Ultrasound's maturity stage?
Is Butterfly AI Ultrasound safe?
How much does the Butterfly iQ3 ultrasound cost?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-08
Verification posture
Verified
Medium confidence
Review state
Stable
Last reviewed 2026-07-08
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: biometric
Sources by quality tier
- 1
- secondary-established-publication
- Established publication
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Butterfly AI Ultrasound.Recent coverage
Butterfly AI Ultrasound in third-party press
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning Butterfly AI Ultrasound from third-party publications. Automatically surfaced; not part of the verified registry record.
Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool
Butterfly received FDA clearance for a fully automated Gestational Age Tool integrated into its handheld ultrasound, a milestone for women's health.
Butterfly Network gets FDA clearance for AI ultrasound pregnancy tool
FDA cleared Butterfly Network's AI ultrasound tool for fetal biometric measurements. 21M+ images. Under 2 minutes.
Butterfly Network Reports Fourth Quarter 2025 Financial Results
Butterfly reported record Q4 revenue of 31.5M USD with 41 percent YoY growth and positive net cash flow.
Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool
Butterfly Network received FDA clearance for its blind sweep ultrasound AI tool for pregnancy, delivering fetal biometric estimates in under two minutes without requiring users to…
Butterfly Network Reports Fourth Quarter 2024 Financial Results
Butterfly Network reported Q4 2024 total revenue of $22.4 million, up 35% year-over-year, with US revenue of $14.5 million.
Butterfly Announces FDA Clearance of its Next-Gen Handheld Ultrasound Butterfly iQ3
Butterfly Network received FDA clearance for the Butterfly iQ3, its next-generation handheld ultrasound with improved image quality and new digital imaging modes.
Butterfly Network Names Joseph M. DeVivo as President and Chief Executive Officer
Butterfly appointed health tech executive Joseph DeVivo as CEO and Chairman, bringing over 35 years of medtech leadership experience.
Butterfly Network Distributes 500 Butterfly iQ+ Devices to Healthcare Workers in Kenya
Butterfly deployed 500 iQ+ devices to healthcare workers in Kenya as part of a 5M USD Gates Foundation grant to expand medical imaging access in Sub-Saharan Africa.
Mintz Represents Butterfly Network in 1.5B USD SPAC Deal
Butterfly Network merged with Longview Acquisition Corp in a SPAC deal valuing the company at approximately 1.5B USD ahead of its NYSE listing.
Atrium Health and Butterfly Network Drive Innovation in Medical Imaging During COVID-19 Battle
Atrium Health deployed a large fleet of Butterfly iQ devices used to perform thousands of scans during the COVID-19 pandemic.
Machine-readable surfaces
- Markdown mirror: /models/butterfly-ai-ultrasound.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/b2d13502-17cd-4a08-a041-1975cd143852
- Revision history: /models/butterfly-ai-ultrasound/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
Butterfly AI Ultrasound draws attention at the 42nd percentile but verifies reality at the 31st percentile among biometric robots. Hype Gap +11.4, 10th widest among biometric robots.
6-month trend
Analysis
Limited independent press and video coverage to date.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 18, 2026